The Role of Plasma, Platelets, and Growth Factors in Knee Osteoarthritis: The Evidence-Based Medicine 2022

Authors

  • Vorasilp Cheeva-akrapan, MD Biomedical Technology Research and Development Center, Police General Hospital, Bangkok, Thailand
  • Thana Turajane, MD Biomedical Technology Research and Development Center, Police General Hospital, Bangkok, Thailand

DOI:

https://doi.org/10.56929/jseaortho.v46i2.34

Keywords:

orthobiologics, plasma, platelets, growth factors, knee osteoarthritis

Abstract

Knee osteoarthritis greatly affects the quality of life of numerous people worldwide. Study in 2020 estimated that the global incidence of knee osteoarthritis was 203 per 10,000 person-years and the global prevalence was 16%. Biologic derivatives, such as plasma, platelets, and growth factors, have gained popularity due to their efficacy and safety; however, several controversies related to the treatment of knee osteoarthritis with orthobiologics still exist. The purpose of this review is to provide recent evidence about the use of growth factors as orthobiologics for the treatment of knee osteoarthritis, to summarize the up-to-date clinical practice guidelines provided by American Academy of Orthopedic Surgeons (AAOS) and American College of Rheumatology (ACR), and to discuss these guidelines based on the latest research.

Metrics

Metrics Loading ...

References

Delanois RE, Etcheson JI, Sodhi N, et al. Biologic therapies for the treatment of knee osteoarthritis. J Arthroplasty 2019;34:801-13.

Jones IA, Togashi R, Wilson ML, et al. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 2019;15:77-90.

Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013;9: 400-10.

Elik H, Yilmaz F, Begoglu FA, et al. The efficiency of platelet-rich plasma treatment in patients with knee osteoarthritis. J Back Musculoskelet Rehabil 2020;33:127-38.

Delanois RE, Mistry JB, Gwam CU, et al. Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty 2017;32: 2663-8.

Iriart JA. Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century. Cad Saude Publica 2019;35:e00153118.

Githens M. Helping fractures heal (Orthobiologics). 2020 [2022 Feb 1]. Available from: https://orthoinfo.aaos.org/en/treatment/ helping-fractures-heal-orthobiologics

Bakhshayesh AR, Babaie S, Nasrabadi HT, et al. An overview of various treatment strategies, especially tissue engineering for damaged articular cartilage. Artif Cells Nanomed Biotechnol 2020;48:1089-104.

Son KM, Hong JI, Kim DH, et al. Absence of pain in subjects with advanced radiographic knee osteoarthritis. BMC Musculoskelet Disord 2020; 21:640.

Kuttapitiya A, Assi L, Laing K, et al. Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis 2017;76:1764-73.

McGonagle D, Baboolal TG, Jones E. Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis. Nat Rev Rheumatol 2017;13:719-30.

Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 2011;7:43-9.

Huang L, Guo B, Xu Feixiang, et al. Effects of quadricepts functional exercise with isometric contraction in the treatment of knee osteoarthritis. Int J Rheum Dis 2018;21:952-9.

Link JM, Salinas EY, Hu JC, et al. The tribology of cartilage: mechanisms, experimental techniques, and relevance to translational tissue engineering. Clin Biomech (Bristol, Avon) 2020; 79:104880.

Vannabouathong C, Bhandari M, Bedi A, et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: A systematic

review. JBJS Rev 2018;6:e5.

Turajane T, Thitiset T, Honsawek S, et al. Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold. Musculoskelet Surg 2014;98:35-43.

Thon JN, Italiano JE. Platelets: production, morphology, and ultrastructure. Handb Exp Pharmacol 2012;(210):3-22.

Anitua E, Sanchez M, Orive G, et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28:4551-60.

Rendu F, Brohard-Bohn B. The platelet release reaction: granules’ constituents, secretion and functions. Platelets 2001;12:261-73.

Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: New performance understandings and therapeutic considerations in 2020. Int J Mol Sci 2020;21:7794.

Chala J, Cinque ME, Piuzzi N, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: A systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017;99:1769-79.

Nikolovska B, Miladinova D, Pejkova S, et al. Platelet-rich plasma – review of literature. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2021;42:127-39.

Fitzpatrict J, Bulsara ML, McCrory PR, et al. Analysis of Platelet-rich plasma extraction. Orthop J Sports Med 2017;5:2325967116675272.

Fadadu PP, Mazzola AJ, Hunter CW, et al. Review of concentration yields in commercially available platlet-rich plasma (PRP) system: a call for PRP standardization. Reg Anesth Pain Med 2019;44:652-9.

DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy 2012;28:998-1009.

Oh JH, Kim WK, Park KU, et al. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med 2015;43:3062-70.

Lang S, Loibl M, Hermann M. Platelet-rich plasma in tissue engineering: hype and hope. Eur Surg Res 2018;59:265-75.

Lana JF, Huber SC, Purita J, et al. Leukocyte-rich PRP versus leukocyte-poor PRP – The role of monocyte/macrophage function in the healing cascade. J Clin Orthop Trauma 2019;10Suppl1: S7-12.

Gentile P, Garcovich S. Systematic review-the potential implications of different platelet-rich plasma (PRP) concentration in regenerative medicine for tissue repair. Int J Mol Sci 2020;21: 5702.

Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004;34: 665-71.

Riboh JC, Saltzman BM, Yanke AB, et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 2016;44:792-800.

Lana JF, Macedo A, Ingrao ILG, et al. Leukocyte-rich PRP for knee osteoarthritis: Current concepts. J Clin Orthop Trauma 2019;10Suppl1: S179-82.

American academy of orthopaedic surgeons management of osteoarthritis of the knee (non-arthroplasty) evidence-based clinical practice guideline. Available from: https://www.aaos.org/oak3cpg. Accessed August 31, 2021.

Futa D, Shealy B, Jacobson M, et al. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg 2008;66:684-90.

Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of rhematology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 2020;72:220-33.

Johal H, Khan M, Yung SP, et al. Impact of platelet-rich plasma use on pain in orthopaedic surgery: A systematic review and meta-analysis. Sports Health 2019;11:355-66.

Nie L, Zhao K, Ruan J, et al. Effectiveness of platelet-rich plasma in the treatment of knee osteoarthritis: A meta-analysis of randomized controlled clinical trials. Orthop J Sports Med 2021; 9:2325967120973284.

Turajane T, Sriratanavudhi C, Saengsirinavin P, et al. Safety and clinical efficacy of platelet rich growth factors (PRGF) in managing knee osteoarthritis after failed conservative treatment: evidence from real practices. J Southeast Asian Med Res 2019;3:1-7.

Turajane T, Saengsirinavin P, Sriratanavudhi C, et al. A prospective, randomized, controlled trial comparing clinical outcomes of intraarticular platelet plasma concentrate and growth factors versus corticosteroid injections in the treatment of knee osteoarthritis. BKK Med J 2021;17:9-14.

Ngarmukos S, Tanavalee C, Amarase C, et al. Two or four injections of platelet-rich plasma for osteoarthritic knee did not change synovial biomarkers but similarly improved clinical outcomes. Sci Rep 2021;11:23603.

Riewruja K, Phakham S, Sompolpong P, et al. Cytokine profiling and intra-articular injection of autologous platelet-rich plasma in knee osteoarthritis. Int J Mol Sci 2022;23:890.

Downloads

Published

2022-07-28

How to Cite

1.
Cheeva-akrapan, MD V, Turajane, MD T. The Role of Plasma, Platelets, and Growth Factors in Knee Osteoarthritis: The Evidence-Based Medicine 2022. JseaOrtho [Internet]. 2022 Jul. 28 [cited 2022 Oct. 7];46(2):31-8. Available from: https://www.jseaortho.org/index.php/jsao/article/view/34

Issue

Section

Review Articles

Similar Articles

You may also start an advanced similarity search for this article.